{"data":{"id":"us-wv/w.-va.-code-33-54-4","jurisdiction":"us-wv","citation":"W. Va. Code § 33-54-4","heading":"Health benefit plan issuer reporting requirements.","body":"No later than March 1 of each calendar year, each health benefit plan issuer shall submit to the Auditor a report providing the following information for the immediately preceding calendar year: Provided, That nothing in this article should be construed as to requiring a health benefit plan issuer to disclose confidential health information protected by the Health Insurance Portability and Accountability Act:\n(1) The names of the 25 most frequently prescribed prescription drugs across all plans;\n(2) The percent increase in annual net spending for prescription drugs across all plans;\n(3) The percent increase in premiums that were attributable to prescription drugs across all plans;\n(4) The percentage of specialty drugs with utilization management requirements across all plans; and\n(5) The premium reductions that were attributable to specialty drug utilization management.","path":["CHAPTER 33. INSURANCE.","ARTICLE 54. REQUIRING ACCOUNTABLE PHARMACEUTICAL TRANSPARENCY, OVERSIGHT, AND REPORTING ACT."],"source_url":"https://code.wvlegislature.gov/33-54-4/","current_through":"as of 2026-08-03; contains at least the enactments of the 2026 Regular Session","vintage":"","retrieved_at":"2026-09-06T00:28:55Z","sha256":"6e51d78ad77f1ad047164abb0fc963bbeef63556e81fa6f1b3ddb56a07ec7d66","source_id":"us-wv","stale":true,"prev":"us-wv/w.-va.-code-33-54-3","next":"us-wv/w.-va.-code-33-54-5"},"notice":"GroundRules: Original legal text. Not legal advice."}